Forbes January 7, 2024
Bruce Japsen

Walgreens chief executive’s disclosure last week that VillageMD’s doctor-staffed clinic expansion plan needed to go “on a diet” highlights certain risks in the race by retailers to open primary care centers across the country.

In Walgreens case, the drugstore giant has for several years now been an investor and partner with VillageMD, a Chicago-based startup that has received several billion dollars from Walgreens. Walgreens, which now owns about half of VillageMD, in October announced plans to close 60 underperforming VillageMD locations and exit certain locations to focus on “increased density” in the company’s highest opportunity markets.

In an interview last week, Walgreens chief executive Tim Wentworth said Walgreens and partner VillageMD have slowed the number of openings of doctor-staffed clinics...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech, Primary care, Provider, Retailer
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article